Minimally invasive versus open transforaminal lumbar fusion: a systematic review of complications

Wei Hu1, Jiandong Tang2, Xianpei Wu2

  • 1Department Spine and Osteopathy Ward, Guilin Peoples' Hospital, No 12 Wenming road, Guilin, Guangxi, China, 540021. howie189@126.com.

Abstract

Insights

Minimally invasive transforaminal lumbar interbody fusion (mTLIF) may reduce blood loss and hospital stay compared to open transforaminal lumbar interbody fusion (oTLIF). However, mTLIF requires longer operative times and increased radiation exposure, necessitating further high-quality trials.

Area of Science:

  • Spinal surgery
  • Orthopedic surgery
  • Neurosurgery

Background:

  • Transforaminal lumbar interbody fusion (TLIF) is a common surgical procedure for degenerative spinal conditions.
  • Two primary approaches exist: minimally invasive (mTLIF) and open (oTLIF).
  • Comparative data on their peri-operative outcomes are crucial for surgical decision-making.

Purpose of the Study:

  • To systematically compare the peri-operative outcomes of minimally invasive TLIF (mTLIF) versus open TLIF (oTLIF).
  • Key outcome measures include complications, operative time, blood loss, fluoroscopic time, and hospital stay.

Main Methods:

  • A systematic review and meta-analysis of studies comparing mTLIF and oTLIF.
  • Databases searched include PubMed and EMBASE.
  • Data extracted included patient demographics, complications, operative time, estimated blood loss, fluoroscopic time, and length of hospital stay.

Main Results:

  • Fourteen studies involving 901 patients (455 mTLIF, 446 oTLIF) were analyzed.
  • mTLIF demonstrated significantly lower estimated blood loss (51-578 ml vs. 225-961 ml) and shorter hospital stays (2.3-10.6 days vs. 2.9-14.6 days).
  • mTLIF had a lower overall complication rate (11.87% vs. 14.35%) but longer operative times (116-390 min vs. 102-365 min) and increased fluoroscopic exposure (49-106 sec vs. 16.4-44 sec).

Conclusions:

  • mTLIF offers potential advantages in reduced blood loss, shorter hospital stays, and lower complication rates compared to oTLIF.
  • These benefits are offset by increased operative time and radiation exposure.
  • High-quality randomized controlled trials (Class I evidence) are recommended for definitive conclusions.

Related Concept Videos